1. Home
  2. PLSE vs GRDN Comparison

PLSE vs GRDN Comparison

Compare PLSE & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • GRDN
  • Stock Information
  • Founded
  • PLSE 2014
  • GRDN 2004
  • Country
  • PLSE United States
  • GRDN United States
  • Employees
  • PLSE N/A
  • GRDN N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • PLSE Health Care
  • GRDN Consumer Staples
  • Exchange
  • PLSE Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • PLSE 1.3B
  • GRDN 1.2B
  • IPO Year
  • PLSE 2016
  • GRDN 2024
  • Fundamental
  • Price
  • PLSE $16.99
  • GRDN $19.31
  • Analyst Decision
  • PLSE
  • GRDN Strong Buy
  • Analyst Count
  • PLSE 0
  • GRDN 2
  • Target Price
  • PLSE N/A
  • GRDN $22.50
  • AVG Volume (30 Days)
  • PLSE 154.6K
  • GRDN 50.8K
  • Earning Date
  • PLSE 05-06-2025
  • GRDN 03-26-2025
  • Dividend Yield
  • PLSE N/A
  • GRDN N/A
  • EPS Growth
  • PLSE N/A
  • GRDN N/A
  • EPS
  • PLSE N/A
  • GRDN N/A
  • Revenue
  • PLSE N/A
  • GRDN $1,170,907,000.00
  • Revenue This Year
  • PLSE N/A
  • GRDN $18.62
  • Revenue Next Year
  • PLSE N/A
  • GRDN $9.51
  • P/E Ratio
  • PLSE N/A
  • GRDN N/A
  • Revenue Growth
  • PLSE N/A
  • GRDN 16.86
  • 52 Week Low
  • PLSE $6.60
  • GRDN $14.16
  • 52 Week High
  • PLSE $25.00
  • GRDN $25.74
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 36.10
  • GRDN N/A
  • Support Level
  • PLSE $16.48
  • GRDN N/A
  • Resistance Level
  • PLSE $17.91
  • GRDN N/A
  • Average True Range (ATR)
  • PLSE 1.22
  • GRDN 0.00
  • MACD
  • PLSE -0.21
  • GRDN 0.00
  • Stochastic Oscillator
  • PLSE 14.39
  • GRDN 0.00

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.

Share on Social Networks: